Klotho Neurosciences, Inc.

Nasdaq:KLTONasdaq:KLTOW

Biological Products, (No Diagnostic Substances)·OMAHA, NE

Financials

16 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/18/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/19/24	→
10-Q	Q2 2024	6/30/24	8/19/24	→
↓

News (8-K)

57 shown

Filed	Type	Description
3/4/26	Reg FD	Regulation FD Disclosure	→
3/2/26	Other	Unregistered Sales of Equity Securities	→
2/24/26	Agreement	Entry into a Material Definitive Agreement	→
2/17/26	Vote	Submission of Matters to a Vote of Security Holders	→
12/8/25	Agreement	Entry into a Material Definitive Agreement	→
9/25/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

26 shown

Filed	Form	Description
2/24/26	424B3	PROSPECTUS SUPPLEMENT	→
12/5/25	S-1	REGISTRATION STATEMENT	→
11/6/25	S-8	REGISTRATION STATEMENT	→
9/30/25	424B3	PROSPECTUS SUPPLEMENT	→
7/28/25	424B5	PROSPECTUS SUPPLEMENT	→
7/28/25	424B3	PROSPECTUS SUPPLEMENT	→
↓

Filing History(209 filings)

TypeDateAccessionPeriodSize

Mar 6, 2026

0001213900-26-024661PRIMARY DOCUMENT

Mar 4, 2026

4.8 KB

Mar 6, 2026

0001213900-26-024627PRIMARY DOCUMENT

Mar 4, 2026

4.7 KB

Mar 6, 2026

0001213900-26-024613PRIMARY DOCUMENT

Mar 4, 2026

4.8 KB

Mar 6, 2026

0001213900-26-024610PRIMARY DOCUMENT

Mar 4, 2026

4.8 KB

Mar 6, 2026

0001213900-26-024590PRIMARY DOCUMENT

Mar 4, 2026

4.8 KB

Mar 6, 2026

0001213900-26-024574PRIMARY DOCUMENT

Mar 4, 2026

4.8 KB

8-K

Mar 4, 2026

0001213900-26-023666CURRENT REPORT

Mar 4, 2026

276.5 KB

8-K

Mar 2, 2026

0001213900-26-022411CURRENT REPORT

Feb 27, 2026

231.3 KB

424B3

Feb 24, 2026

0001213900-26-019509PROSPECTUS SUPPLEMENT

—

130.0 KB

8-K

Feb 24, 2026

0001213900-26-019436CURRENT REPORT

Feb 19, 2026

455.6 KB

8-K

Feb 17, 2026

0001213900-26-017490CURRENT REPORT

Feb 17, 2026

235.8 KB

DEFR14A

Jan 26, 2026

0001213900-26-007798PROXY STATEMENT

—

344.9 KB

DEF 14A

Jan 23, 2026

0001213900-26-007332PROXY STATEMENT

Feb 13, 2026

342.2 KB

PRE 14A

Jan 12, 2026

0001213900-26-003366PROXY STATEMENT

Jan 12, 2026

336.4 KB

EFFECT

Dec 12, 2025

9999999995-25-003720

—

1.9 KB

Dec 10, 2025

0001213900-25-119999PRIMARY DOCUMENT

Dec 10, 2025

5.4 KB

Dec 10, 2025

0001213900-25-119998PRIMARY DOCUMENT

Dec 10, 2025

5.4 KB

Dec 10, 2025

0001213900-25-119993PRIMARY DOCUMENT

Dec 10, 2025

5.3 KB

8-K

Dec 8, 2025

0001213900-25-119257CURRENT REPORT

Dec 2, 2025

391.0 KB

S-1

Dec 5, 2025

0001213900-25-118825REGISTRATION STATEMENT

—

489.2 KB

10-Q

Nov 13, 2025

0001213900-25-109920QUARTERLY REPORT

Sep 30, 2025

5.4 MB

S-8

Nov 6, 2025

0001213900-25-107084REGISTRATION STATEMENT

—

415.4 KB

424B3

Sep 30, 2025

0001213900-25-093911PROSPECTUS SUPPLEMENT

—

94.1 KB

Sep 29, 2025

0001213900-25-092929PRIMARY DOCUMENT

Sep 25, 2025

5.0 KB

8-K

Sep 25, 2025

0001213900-25-091661CURRENT REPORT

Sep 19, 2025

249.4 KB

25 filings shown

Klotho Neurosciences, Inc.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(209 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/26/26	DEFR14A	DEFR14A	→
1/23/26	DEF 14A	DEF 14A	→
1/12/26	PRE 14A	PRE 14A	→
5/28/25	PRE 14A	PRE 14A	→
5/5/25	DEF 14A	DEF 14A	→
3/27/25	PRE 14A	PRE 14A	→
↓

Filed	Form	Description
3/6/26	4	PRIMARY DOCUMENT	→
3/6/26	4	PRIMARY DOCUMENT	→
3/6/26	4	PRIMARY DOCUMENT	→
3/6/26	4	PRIMARY DOCUMENT	→
3/6/26	4	PRIMARY DOCUMENT	→
3/6/26	4	PRIMARY DOCUMENT	→
↓

Filed	Form	Description
12/12/25	EFFECT	EFFECT	→
7/25/25	EFFECT	EFFECT	→
7/2/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/2/25	SCHEDULE 13G	SCHEDULE 13G	→
2/10/25	EFFECT	EFFECT	→
9/18/24	EFFECT	EFFECT	→
↓